|
Product Description
|
Recall Class
|
FDA Recall Posting Date
|
Recalling Firm
|
Z-0822-2023 - ETEST CLINICAL ERTAPENEM ETP 32 US S30, CATALOG 412331
|
2
|
01/04/2023
|
Biomerieux Inc
|
Z-0851-2023 - ETEST CLINICAL ERAVACYCLINE ERV US S30, CATALOG 421553
|
2
|
01/04/2023
|
Biomerieux Inc
|
Z-0863-2023 - ETEST CLINICAL COLISTIN CO 256 US B100, CATALOG 537348
|
2
|
01/04/2023
|
Biomerieux Inc
|
Z-0821-2023 - ETEST CLINICAL CEFTRIAXONE TX 32 US S30, CATALOG 412302
|
2
|
01/04/2023
|
Biomerieux Inc
|
Z-0841-2023 - ETEST CLINICAL CEFTOLOZANE/TAZO C/T US S30, CATALOG 414445
|
2
|
01/04/2023
|
Biomerieux Inc
|
Z-0846-2023 - ETEST CLINICAL CEFTAZIDIM/AVIBACTAM US S30, CATALOG 419046
|
2
|
01/04/2023
|
Biomerieux Inc
|
Z-0820-2023 - ETEST CLINICAL BENZYLPENICIL PG 256 US S30, CATALOG 412262
|
2
|
01/04/2023
|
Biomerieux Inc
|
Z-0819-2023 - ETEST CLINICAL AMOXI/CLAV 2/1 XL 256 US S30, CATALOG 412252
|
2
|
01/04/2023
|
Biomerieux Inc
|
Z-0818-2023 - ETEST CLINICAL AMOXI/CLAV 2/1 XL 256 US S30, CATALOG 412240
|
2
|
01/04/2023
|
Biomerieux Inc
|
Z-0817-2023 - ETEST CLINICAL AMIKACIN AK 256 US S30, CATALOG 412218
|
2
|
01/04/2023
|
Biomerieux Inc
|